Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aspect Medical to initiate BRITE trial

This article was originally published in The Gray Sheet

Executive Summary

375-patient, 9-center BRITE-MD (Biomarkers for Rapid Identification of Treatment Efficacy-Major Depression) trial begins enrollment in the U.S., with expected trial completion in June 2007. The firm's brain assessment technology, which predicts the effectiveness of antidepressants by analyzing electrical activity in the brain, will be used on patients from 21 to 75 years of age in the trial. According to Aspect, the new technology could help to reduce the number of rounds of pharmaceutical treatment a patient must endure prior to finding an efficacious antidepressant. Prior research by the firm showed that the technology predicted response to antidepressants with more than 80% accuracy (1"The Gray Sheet" Nov. 7, 2005, p. 16)...

You may also be interested in...

Aspect Medical Hopes To Pick Up Momentum From Anesthesia Group’s Ruling

Aspect Medical is trying to capitalize on an American Society of Anesthesiologists advisory on intraoperative awareness as it prepares to launch its BIS Vista brain monitoring system

Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News

The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.

FDA Commissioner Nominee Hahn Advances To Full Senate, Despite Some Dems’ Reservations

Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts